遺伝子増幅技術の市場規模、シェア、成長分析：製品別、サンプルタイプ別、技術別、エンドユーザー別、地域別 - 産業予測 2025～2032年

遺伝子増幅技術の世界市場規模は2023年に281億米ドルと評価され、2024年の301億米ドルから2032年には521億米ドルに成長し、予測期間（2025～2032年）のCAGRは7.1％で成長する見通しです。

世界の遺伝子増幅技術市場は、分子生物学や診断手法の革新によって大きな成長を遂げています。この動向を牽引する主な要因には、疾病診断、個別化医療、バイオテクノロジー研究におけるこれらの技術の利用拡大が含まれます。市場を独占しているのは、ポリメラーゼ連鎖反応（PCR）と等温増幅技術であり、CRISPRベースの増幅が注目すべき競合として台頭しています。北米は、広範な研究開発イニシアティブと強固なヘルスケアフレームワークに支えられ、大きな市場シェアを維持しています。一方、アジア太平洋地域は、ヘルスケア支出の増加と技術の進歩により、急速な成長を遂げています。ゲノミクス分野が医療・研究用途に革命を起こし続ける中、遺伝子増幅技術市場は成長軌道を維持すると予想されます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術の進歩

遺伝子増幅技術市場規模：製品別

• 市場概要
• 機器
• キットと試薬
• ソフトウェアとサービス

遺伝子増幅技術市場規模：サンプルタイプ別

• 市場概要
• 細胞株
• 農業・食品サンプル
• 体液
• 組織
• その他

遺伝子増幅技術市場規模：技術別

• 市場概要
• PCRベースの増幅
• ループ媒介等温増幅
• 核酸配列に基づく増幅
• 鎖置換増幅
• 多重変位増幅
• ローリングサークル増幅
• 分岐増幅
• その他

遺伝子増幅技術市場規模：エンドユーザー別

• 市場概要
• 製薬・バイオテクノロジー企業
• 学術機関および調査機関
• 病院と診断ラボ
• 契約調査機関
• 法医学研究所
• その他

遺伝子増幅技術市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• QIAGEN（Germany）
• New England Biolabs（United States）
• Illumina Inc.（United States）
• Yikang Gene（China）
• Bio-Rad Laboratories（United States）
• Menarini Silicon Biosystems（Italy）
• Merck KGaA（Germany）
• Promega Corporation（United States）
• Takara Bio Inc.（Japan）
• Danaher Corporation（United States）
• 4basebio AG（Germany）
• LGC Group（United Kingdom）
• Vazyme Biotech Co. Ltd.（China）
• MyBioSource（United States）
• 10x Genomics（United States）
• Ginkgo Bioworks（United States）
• Thermo Fisher Scientific（United States）
• Agilent Technologies（United States）
• Roche Diagnostics（Switzerland）
• Becton, Dickinson and Company（United States）

結論と提言

Global Gene Amplification Technologies Market size was valued at USD 28.1 billion in 2023 and is poised to grow from USD 30.1 billion in 2024 to USD 52.1 billion by 2032, growing at a CAGR of 7.1% during the forecast period (2025-2032).

The global gene amplification technologies market is witnessing substantial growth, spurred by innovations in molecular biology and diagnostic methodologies. Major factors driving this trend include the escalating use of these technologies in disease diagnosis, personalized medicine, and biotechnology research. Dominating the market are polymerase chain reaction (PCR) and isothermal amplification techniques, with CRISPR-based amplification emerging as a notable contender. North America maintains a significant market share, bolstered by extensive R&D initiatives and a robust healthcare framework. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increased healthcare spending and technological advancements. As the field of genomics continues to revolutionize medical and research applications, the gene amplification technologies market is expected to maintain its growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gene Amplification Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gene Amplification Technologies Market Segments Analysis

Global Gene Amplification Technologies Market is segmented by Product, Sample Type, Technology, End-user and region. Based on Product, the market is segmented into Instruments, Kits and Reagents and Software & Services. Based on Sample Type, the market is segmented into Cell Lines, Agricultural & Food Samples, Body Fluids, Tissue and Others. Based on Technology, the market is segmented into PCR-based Amplification, Loop-mediated Isothermal Amplification, Nucleic-Acid Sequence Based Amplification, Strand Displacement Amplification, Multiple Displacement Amplification, Rolling Circle Amplification, Ramification Amplification and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academics & Research Institutes, Hospitals & Diagnostic Labs, Contract Research Organizations, Forensic Labs and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gene Amplification Technologies Market

The global gene amplification technologies market is experiencing significant growth driven by the rising demand for personalized medicine and the ongoing advancements in biotechnology. These innovative technologies facilitate precise and efficient analysis of genetic material, which is crucial for both diagnostic and research applications. As healthcare increasingly shifts toward tailored treatments and diagnostic methods, the need for accurate gene amplification solutions is surging. This trend underscores the importance of gene amplification technologies in enabling researchers and clinicians to better understand genetic information and develop effective, individualized healthcare strategies, further fueling the expansion of this dynamic market.

Restraints in the Global Gene Amplification Technologies Market

The Global Gene Amplification Technologies market faces several restraints that may impede its growth and broader acceptance. Ethical issues related to genetic manipulation create significant apprehension among stakeholders, while complicated regulatory frameworks add layers of complexity and uncertainty to the development and commercialization processes. Additionally, the high costs associated with implementing gene amplification technologies can deter investment and adoption, further limiting their reach and potential impact. Collectively, these factors contribute to challenges in expanding the market, making it essential for industry players to navigate these obstacles effectively to promote growth and innovation within this vital sector.

Market Trends of the Global Gene Amplification Technologies Market

The global gene amplification technologies market is experiencing significant growth, driven by advancements in CRISPR-Cas9 technology, which enables precise and efficient gene editing. The increasing applications of these technologies in medical research, agriculture, and biotechnology are further driving expansion. The rise of synthetic biology and personalized medicine is fueling demand for innovative gene amplification tools, while automation and high-throughput capabilities enhance operational efficiency. Despite ethical and regulatory challenges concerning genetic manipulation, the market's trajectory is propelled by continuous innovation, diverse applications, and increased investment in genetic research, focusing on both therapeutic and non-therapeutic applications. This trend underscores the critical role of gene amplification technologies in shaping the future of various industries.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Gene Amplification Technologies Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Kits and Reagents
• Software & Services

Global Gene Amplification Technologies Market Size by Sample Type & CAGR (2025-2032)

• Market Overview
• Cell Lines
• Agricultural & Food Samples
• Body Fluids
• Tissue
• Others

Global Gene Amplification Technologies Market Size by Technology & CAGR (2025-2032)

• Market Overview
• PCR-based Amplification
• Loop-mediated Isothermal Amplification
• Nucleic-Acid Sequence Based Amplification
• Strand Displacement Amplification
• Multiple Displacement Amplification
• Rolling Circle Amplification
• Ramification Amplification
• Others

Global Gene Amplification Technologies Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academics & Research Institutes
• Hospitals & Diagnostic Labs
• Contract Research Organizations
• Forensic Labs
• Others

Global Gene Amplification Technologies Market Size & CAGR (2025-2032)

• North America (Product, Sample Type, Technology, End-user)
  • US
  • Canada
• Europe (Product, Sample Type, Technology, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Sample Type, Technology, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Sample Type, Technology, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Sample Type, Technology, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Yikang Gene (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Menarini Silicon Biosystems (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 4basebio AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Group (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vazyme Biotech Co. Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MyBioSource (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ginkgo Bioworks (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations